Advancing Clinical Research in Primary Glomerular Diseases (UM1)
The purpose of this Funding Opportunity Announcement (FOA) is to support translational and clinical research that promotes therapeutic development for primary glomerular diseases. The emphasis of this FOA is specifically on chronic forms of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), immunoglobulin A nephropathy (IGAN), and idiopathic membranous nephropathy (IMN).
General information about this opportunity
Last Known Status
Deleted 03/30/2013 (Archived.)
Program Number
RFA-DK-12-014 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: National Institutes of Health
Type(s) of Assistance Offered
Cooperative Agreement Number of Awards Available
5 Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. What is the process for applying and being award this assistance?
Deadlines
02/27/2013 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Website Address
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-014.html
E-mail Address
FBOWebmaster@OD.NIH.GOV
Financial Information
Obligations
$3,000,000.00
